Experience
Senti Biosciences Sells Certain Assets to Celadon Partners
August 14, 2023
Cooley advised Senti Biosciences, a biotechnology company, on its sale of certain assets – including its manufacturing facility and chemistry, manufacturing, and controls capabilities – to Celadon Partners.
Related contacts
Related Practices & Industries
Sprout Social Acquires Tagger Media
August 4, 2023
Cooley advised Sprout Social, a social media management software company, on its $140 million acquisition of Tagger Media, a top influencer marketing platform, and a concurrent $100 million secured debt facility, which will be partially used to fund the acquisition.
Related contacts
Related Practices & Industries
Bridge to Life Sells Certain Assets to TransMedics
August 3, 2023
Cooley advised Bridge to Life, an organ preservation and perfusion technologies supplier, on its sale of certain assets – including its EVOSS heart and lung and LifeCradle heart perfusion assets – to TransMedics.
Related contacts
Related Practices & Industries
Moogsoft Agrees to Sell to Dell
July 19, 2023
Cooley advised Moogsoft, an artificial intelligence-driven provider of intelligent monitoring solutions that support DevOps and ITOps, on its agreement to sell to Dell Technologies. Lawyers Steve Tonsfeldt, Mark Tanoury, Sangitha Palaniappa and Allison Peth led the Cooley team advising Moogsoft.
Related contacts
Related Practices & Industries
Morphimmune Announces Merger With Immunome and $125 Million Private Investment
July 5, 2023
Cooley advised Morphimmune, a private biotechnology company, in its definitive merger agreement with Immunome and $125 million private investment.